MARAVAI LIFESCIENCES HOLDINGS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Benjamin Daverman

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Benjamin Daverman”): 193,739,240 for, 33,663,940 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 22,545,130 for, 10,271,675 withheld.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Susannah Gray

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Susannah Gray”): 193,773,793 for, 33,629,387 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 22,524,879 for, 10,291,926 withheld.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Carl Hull

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Carl Hull”): 196,078,626 for, 31,324,554 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 26,385,517 for, 6,431,288 withheld.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: To elect four nominees to the Board of Directors (3-year term expiring in 2027): Constantine Mihas

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“Elect Director: Constantine Mihas”): 191,415,297 for, 35,987,883 withheld, per its Form 8-K filed May 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's shareholders elected the following nominees for director to serve for three-year terms expiring at the Company's 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 20,487,423 for, 12,329,382 withheld.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“3. Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting”): 223,303,654 for, 4,747,004 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's shareholders approved, on a non-binding and advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 65 managers: 32,814,843 for, 2 against, 1,960 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 182 managers: 45,556,029 for, 3,635,890 against, 9 withheld, 174,231 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as Maravai's independent registered public accounting firm for the year ending December 31, 2024;

MARAVAI LIFESCIENCES HOLDINGS INC.’s own tally for this item (“2. Proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 236,288,478 for, 268,742 against — passed, per its Form 8-K filed May 28, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 was ratified by the Company's shareholders.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 65 asset managers below reported 32,814,843 for, 2 against, 1,960 abstained.

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.